Metformin overcomes resistance to cisplatin in triple-negative breast cancer (TNBC) cells by targeting RAD51

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1465-542X
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Metformin overcomes resistance to cisplatin in triple-negative breast cancer (TNBC) cells by targeting RAD51 ; volume:21 ; number:1 ; day:22 ; month:10 ; year:2019 ; pages:1-18 ; date:12.2019
Breast cancer research ; 21, Heft 1 (22.10.2019), 1-18, 12.2019

Creator
Lee, Jung Ok
Kang, Min Ju
Byun, Won Seok
Kim, Shin Ae
Seo, Il Hyeok
Han, Jeong Ah
Moon, Ji Wook
Kim, Ji Hae
Kim, Su Jin
Lee, Eun Jung
Park, Serk In
Park, Sun Hwa
Kim, Hyeon Soo
Contributor
SpringerLink (Online service)

DOI
10.1186/s13058-019-1204-2
URN
urn:nbn:de:101:1-2020021603044333758560
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:57 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Lee, Jung Ok
  • Kang, Min Ju
  • Byun, Won Seok
  • Kim, Shin Ae
  • Seo, Il Hyeok
  • Han, Jeong Ah
  • Moon, Ji Wook
  • Kim, Ji Hae
  • Kim, Su Jin
  • Lee, Eun Jung
  • Park, Serk In
  • Park, Sun Hwa
  • Kim, Hyeon Soo
  • SpringerLink (Online service)

Other Objects (12)

A novel small molecule RAD51 inactivator overcomes imatinib‐resistance in chronic myeloid leukaemia

A novel small molecule RAD51 inactivator overcomes imatinib‐resistance in chronic myeloid leukaemia

CircRNA-CREIT inhibits stress granule assembly and overcomes doxorubicin resistance in TNBC by destabilizing PKR

CircRNA-CREIT inhibits stress granule assembly and overcomes doxorubicin resistance in TNBC by destabilizing PKR

Diagnosis and Therapy of Triple-Negative Breast Cancer (TNBC) – Recommendations for Daily Routine Practice

Diagnosis and Therapy of Triple-Negative Breast Cancer (TNBC) – Recommendations for Daily Routine Practice

Rad51 inhibition sensitizes breast cancer stem cells to PARP inhibitor in triple-negative breast cancer

Rad51 inhibition sensitizes breast cancer stem cells to PARP inhibitor in triple-negative breast cancer

The molecular subtyping and precision medicine in triple-negative breast cancer---based on Fudan TNBC classification

The molecular subtyping and precision medicine in triple-negative breast cancer---based on Fudan TNBC classification

Germline TP53 and MSH6 mutations implicated in sporadic triple-negative breast cancer (TNBC): a preliminary study

Germline TP53 and MSH6 mutations implicated in sporadic triple-negative breast cancer (TNBC): a preliminary study

HuR inhibition overcomes cFLIP-mediated doxorubicin resistance in triple-negative breast cancer

HuR inhibition overcomes cFLIP-mediated doxorubicin resistance in triple-negative breast cancer

Analysis of CXCL11 expression in high-grade serous ovarian cancer (HGSOC) and triple-negative breast cancer (TNBC)

Analysis of CXCL11 expression in high-grade serous ovarian cancer (HGSOC) and triple-negative breast cancer (TNBC)

Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 study

Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 study

Poetry overcomes boundaries

Anthologie | Lyrik

Poetry overcomes boundaries

PDZK1 suppresses TNBC development and sensitizes TNBC cells to erlotinib via the EGFR pathway

PDZK1 suppresses TNBC development and sensitizes TNBC cells to erlotinib via the EGFR pathway

Green-synthesized silver nanoparticles from peel extract of pumpkin as a potent radiosensitizer against triple-negative breast cancer (TNBC)

Green-synthesized silver nanoparticles from peel extract of pumpkin as a potent radiosensitizer against triple-negative breast cancer (TNBC)

Related objects